Morphologic changes in human immunodeficiency virus type 1 virions secondary to intravirion reverse transcription: Evidence indicating that reverse transcription may not take place within the intact viral core

Journal of Human Virology

Volumn 3, Issue 3, 2000, Pages 165-172

  Zhang, Hui ^a   Dornadula, Geethanjali ^a   Orenstein, Jan ^b   Pomerantz, Roger J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

HIV 1; Intravirion; Morphology; Retrovirus; Reverse transcription

Indexed keywords

ANTIGEN P24; DEOXYRIBONUCLEOSIDE TRIPHOSPHATE; DETERGENT; POLYAMINE;

ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; TRANSMISSION ELECTRON MICROSCOPY; VIRION; VIRUS CORE; VIRUS ENVELOPE; VIRUS INFECTIVITY; VIRUS MORPHOLOGY; VIRUS PARTICLE;

DEOXYRIBONUCLEOTIDES; DNA, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; MICROSCOPY, ELECTRON; POLYMERASE CHAIN REACTION; SPERMIDINE; TRANSCRIPTION, GENETIC; VIRION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0033913638     PISSN: 10909508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Temin HM, Mizutani S. RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature 1970;226:1211-1213.
2. Baltimore D. Viral RNA-dependent DNA polymerase. Nature 1970;226:1209-1211.
3. Gilboa E, Mitra S, Goff S, Baltimore D. A detailed model of reverse transcription and tests of crucial aspects. Cell 1979;18:93-100.
4. Boone LR, Skalka AM. Viral DNA synthesized in vitro by avian retrovirus particles permeabilized with melittin. II. Evidence for a strand displacement mechanism in plus-strand synthesis. J Virol 1981;37:117-126.
5. Yong WH, Wyman S, Levy JA. Optimal conditions for synthesizing complementary DNA in the HIV-1 endogenous reverse transcriptase reaction. AIDS 1990;4:199-206.
6. Borroto-Esoda K, Boone LR. Equine infectious anemia virus and human immunodeficiency virus DNA synthesis in vitro: characterization of the endogenous reverse transcriptase reaction. J Virol 1991;65:1952-1959.
7. Lori F, Veronese FM, DeVico AL, Lusso P, Reitz MS, Gallo RC. Viral DNA carried by human immunodeficiency virus type 1 virions. J Virol 1992;66:5067-5074.
8. Trono D. Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses. J Virol 1992;66:4893-4900.
9. Zhang H, Zhang Y, Spicer TP, Abbott LZ, Abbott M, Poiesz BJ. Reverse transcription takes place within extracellular HIV-1 virions: potential biological significance. AIDS Res Hum Retroviruses 1993;9:1287-1296.
10. Zhang H, Bagasra O, Niikura M, Poiesz BJ, Pomerantz RJ. Intravirion reverse transcripts in the peripheral blood plasma of HIV-1-infected individuals. J Virol 1994;68: 7591-7597.
11. Zhang H, Dornadula G, Pomerantz RJ. Endogenous reverse transcription of human immunodeficiency virus type 1 in physiological microenvironments: an important stage for viral infection of nondividing cells. J Virol 1996; 70:2809-2824.
12. Zhang H, Zhang Y, Spicer T, Denrard D, Poiesz BJ. Nascent human immunodeficiency virus type 1 reverse transcription occurs within an enveloped particle. J Virol 1995;69:3675-3682.
13. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen ISY. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 1990;61:213-222.
14. Zack JA, Haislip AM, Krogstad P, Chen ISY. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life-cycle. J Virol 1992;66:1717-1725.
15. Gao W, Cara A, Gallo RC, Lori F. Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication. Proc Natl Acad Sci U S A 1993;90:8925-8928.
16. Collin M, Gordon S. The kinetics of HIV reverse transcription are slower in primary human macrophages than in a lymphoid cell-line. Virology 1994;200:114-120.
17. O'Brien WA, Namazi A, Kalhor H, Mao S-H, Zack JA, Chen ISY. Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors. J Virol 1994;68:1258-1263.
18. Naldini L, Blomer U, Gage IM, Trono D, Verma IM. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci U S A 1996;93: 11382-11388.
19. Blomer U, Naldini L, Kafri T, Trono D, Verma IM, Gage FH. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J Virol 1997;71:6641-6649.
20. Orenstein JM, Fox C, Wahl SM. Macrophages as a source of HIV during opportunistic infections. Science 1997;276: 1857-1861.
21. Gluschankof PI, Mondor HR, Gelderblom G, Sattentau QJ. Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations. Virology 1997;230:125-133.
22. Bess JW, Gorelikc RJ, Bosche WJ, Henderson LE, Arthur LO. Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations. Virology 1997;230:134-144.
23. Hoglun S, Ofverstedt L-G, Nilsson A, et al. Spatial visualization of the maturing HIV-1 core and its linkage to the envelope. AIDS Res and Human Retroviruses 1992;8:1-5.
24. Gelderblom HR. Assembly and morphology of HIV: potential effect of structure on viral function. AIDS 1991;5: 617-638.
25. Zhang H, Duan L-X, Dornadula G, Pomerantz RJ. Increasing transduction efficiency of recombinant murine retroviral vectors by initiation of endogenous reverse transcription: potential utility for gene therapies. J Virol 1995a;69:3929-3932.
26. Zhang H, Domadula G, Alur P, Laughlin MA, Pomerantz RJ. Amphipathic domains in the C-terminus of the transmembrane protein (gp4l) permeabilize HIV-1 virions: a molecular mechanism underlying natural endogenous reverse transcription. Proc Natl Acad Sci U S A 1996a;93: 12519-12524.
27. Miller MA, Cloyd MW, Liebmann J, et al. Alterations in cell membrane permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein. Virology 1993; 196:89-100.
28. Venable RM, Pastor RW, Brooks BR, Carson FW. Theoretically determined three-dimensional structures for amphipathic segments of the HIV-1 gp41 envelope protein. AIDS Res Hum Retroviruses 1989;5:7-22.
29. Chernomordik L, Chanturiya AN, Suss-Toby E, Nora E, Zimmerberg J. An amphipathic peptide from the C-terminal region of the human immunodeficiency virus envelope glycoprotein causes pore formation in membranes. J Virol 1994;68:7115-7123.
30. Tabor CW, Tabor H. Polyamines. Annu Rev Biochem 1984;53:747-790.
31. Dornadula G, Zhang H, Shetty S, Pomerantz RJ. HIV-1 virions produced from replicating peripheral blood lymphocytes are more infectious than those from non-proliferating macrophages due to higher levels of intravirion reverse transcripts: implications for pathogenesis and transmission. Virology 1999;253:10-16.
32. Gonda MA. Molecular genetics and structure of the human immunodeficiency virus. J Electron Microsc Technol 1988;8:17-40.
33. Ganser BK, Li S, Klishko VY, Finch JT, Sundquist WI. Assembly and analysis of conical models for the HIV-1 core. Science 1999;283:80-83.
34. Clavel F, Orenstein JM. A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology. J Virol 1990;64:5230-5234.
35. Garfinkel DJ, Boeke JD, Fink GR. Ty element transposition: reverse transcriptase and virus-like particles. Cell 1985;42:507-517.
36. Summers J, Mason WS. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 1982;29:403-415.
37. Best S, Le Tissier P, Towers G, Stoye JP. Positional cloning of the mouse retrovirus restriction gene Fv1 [see comments]. Nature 1996;382:826-829.
38. Boone LR, Glover PL, Innes CL, Niver LA, Bondurant MC, Yang WK. Fv-1 N-and B-tropism-specific sequences in murine leukemia virus and related endogenous proviral genomes. J Virol 1988;62:2644-2650.
39. Ou CY, Boone LR, Koh CK, Tennant RW, Yang WK. Nucleotide sequences of gag-pol regions that determine the Fv-1 host range property of BALB/c N-tropic and B-tropic murine leukemia viruses. J Virol 1983;48:779-784.
40. Bowerman B, Brown PO, Bishop JM, Varmus HE. A nucleoprotein complex mediates the integration of retroviral DNA. Genes Develop 1989;3:469-478.
41. Bukrinsky MI, Sharova N, McDonald TL, Pushkarskaya T, Tarpley WG, Stevenson M. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc Natl Acad Sci U S A 1993;90: 6125-6129.
42. Farnet CM, Haseltine WA. Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. J Virol 1991;65:1910-1915.
43. Gallay P, Stitt V, Mundy C, Oettinger M, Trono D. Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. J Virol 1996;70:1027-1032.
44. Miller MD, Farnet CM, Bushman FD. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J Virol 1997;71:5382-5390.
45. Gallay P, Swingler S, Song J, Bushman F, Trono D. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 1995;83:569-576.
46. Dornadula G, Yang S, Pomerantz RJ, Zhang H. Partial rescue of the Vif-negative phenotype of mutant human immunodeficiency virus type 1 strains from nonpermissive cells by intravirion reverse transcription. J Virol 2000; 74:2594-2602.